DRUG compared with MNPR: revenue, margins and what each company keeps, and the suppliers and customers both name

ADRUGBright Minds Biosciences Inc.

BMNPRMonopar Therapeutics

Compare

ADRUGBright Minds Biosciences Inc.

vsBMNPRMonopar Therapeutics

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

Supply-chain overlap

News Companies A–Z Methodology Sources Corrections Terms

Not investment advice. Not a broker-dealer. Prices: Intrinio (indices shown as ETF proxies). Supply-chain data CC BY 4.0; market data not redistributable.

Desk News Calendar Saved

ADRUGBright Minds Biosciences Inc.

54.56▲+0.93%· delayed

BMNPRMonopar Therapeutics

80.54▲+2.00%· delayed

Pre-marketOct 12 '26delayed

Compare

ADRUGBright Minds Biosciences Inc.

54.56▲+0.93%· delayed

vsBMNPRMonopar Therapeutics

80.54▲+2.00%· delayed

Pre-marketOct 12 '26delayed

ADRUG54.56▲+0.93%vsBMNPR80.54▲+2.00%Pre-marketOct 12 '26delayed

Revenue flow

latest quarter · % of own revenueMethod ›

latest quarter · % of own revenue

DRUG: latest quarter not drawable. MNPR: latest quarter not drawable.

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

AOnly DRUG 12

—Board of Trustees of the University of Illinoisunlistedsupplier

—Gerep Realty Corp.unlistedsupplier

—Technology Innovation Center LLCunlistedsupplier

—ZoE Life Fulton Labs Incubator, LLCunlistedsupplier

8 more · DRUG chain ›

Shared 0

No shared counterparties.

BOnly MNPR 2

AZNAstraZenecasupplier

—NorthStarunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR